The FDA has approved San Diego, California-based Dexcom for a Bluetooth-enabled continuous glucose monitor (CGM), called the G5 Mobile CGM system. Correction: A previous version of this article ...
SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring for people with diabetes, announced today the U.S. Centers for Medicare & Medicaid Services (CMS) is ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM) the leader in continuous glucose monitoring (CGM) for people with diabetes, is pleased to announce the Food and Drug Administration (FDA) ...
Dexcom, Inc. (NASDAQ: DXCM), the leader in Continuous Glucose Monitoring (CGM) for people with diabetes, announced today that its G5 Mobile CGM System can now be used with Apple Watches throughout ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する